Hongyan Gou

ORCID

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Venues

Oncogene

This page only lists publications with an associated author ORCID identifier.

Publications

Lingxue Shi, Xiaohong Wang, Shang Guo, Hongyan Gou, Haiyun Shang, Xiaojia Jiang, Chunxian Wei, Jia Wang, Chao Li, Lihong Wang, Zengren Zhao, Weifang Yu, Jun Yu
TMEM65 promotes gastric tumorigenesis by targeting YWHAZ to activate PI3K-Akt-mTOR pathway and is a therapeutic target. Oncogene (2024)
Lingxue Shi, Xiaohong Wang, Shang Guo, Hongyan Gou, Haiyun Shang, Xiaojia Jiang, Chunxian Wei, Jia Wang, Chao Li, Lihong Wang, Zengren Zhao, Weifang Yu, Jun Yu
TMEM65 promotes gastric tumorigenesis by targeting YWHAZ to activate PI3K-Akt-mTOR pathway and is a therapeutic target. Oncogene 43 (13) (2024)
Lingxue Shi, Xiaohong Wang, Shang Guo, Hongyan Gou, Haiyun Shang, Xiaojia Jiang, Chunxian Wei, Jia Wang, Chao Li, Lihong Wang, Zengren Zhao, Weifang Yu, Jun Yu
TMEM65 promotes gastric tumorigenesis by targeting YWHAZ to activate PI3K-Akt-mTOR pathway and is a therapeutic target. Oncogene 43 (13) (2024)
Lingxue Shi, Xiaohong Wang, Shang Guo, Hongyan Gou, Haiyun Shang, Xiaojia Jiang, Chunxian Wei, Jia Wang, Chao Li, Lihong Wang, Zengren Zhao, Weifang Yu, Jun Yu
TMEM65 promotes gastric tumorigenesis by targeting YWHAZ to activate PI3K-Akt-mTOR pathway and is a therapeutic target. Oncogene 43 (13) (2024)
Lingxue Shi, Xiaohong Wang, Shang Guo, Hongyan Gou, Haiyun Shang, Xiaojia Jiang, Chunxian Wei, Jia Wang, Chao Li, Lihong Wang, Zengren Zhao, Weifang Yu, Jun Yu
TMEM65 promotes gastric tumorigenesis by targeting YWHAZ to activate PI3K-Akt-mTOR pathway and is a therapeutic target. Oncogene 43 (13) (2024)

Hongyan Gou.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Hongyan Gou